| |
|

September
2013 Vol. 1 No. 1
Other viewing option
Abstract
• Full
text
•Reprint
(PDF) (136KB)
Search Pubmed for articles by:
Zhang
M
Yiling
Wu
Other links:
PubMed Citation
Related articles in PubMed
|
|
Merit Research Journal of Pharmacy and
Pharmaceutical Sciences Vol. 1(1) pp. 001-007
September, 2013
Copyright © 2013 Merit Research Journals |
|
Full
Length Research Paper
The antioxidant effect of picrosideⅡand
the optimizing of therapeutic dose and time window in cerebral
ischemic injury in rats |
|
| |
| |
|
Meizeng Zhang1*, Pang Fangfang1, Rui
Zhang2, Li Zhao1 and Yiling Wu3 |
|
|
1Department of Neurology,
Affiliated Hospital of Qingdao University Medical College,
Qingdao 266003, China
2Department of ICU, Affiliated Hospital of Qingdao
University Medical College, Qingdao 266003, China
3Department of Rehabilitation, Affiliated Hospital of
Qingdao University Medical College, Qingdao 266003, China
*Corresponding Author's E-mail:
zmzcmd@163.com;
Tel: +8618661808039
Accepted August 26, 2013 |
|
|
Abstract |
|
|
To optimize the antioxidant effect
and the best therapeutic dose and time window of picrosideⅡin
cerebral ischemic injury in rats by orthogonal test. The
forebrain ischemia models were established by bilateral common
carotid artery occlusion (BCCAO) methods. The successful rat
models were randomly divided into 16 groups according to
orthogonal experimental design of [L16(45)]
and treated by injecting picrosideⅡintraperitoneally with
different doses at various times. The concentrations of
malondialdehyde (MDA), nitric oxide (NO) and hydrogen per oxide
(H2O2) in serum and brain tissue were
respectively determined by thiobarbituric acid assay, nitratase
reductase assay and chemiluminescence’s immunoassay. The
optimized compositions of the therapeutic dose and time window
of picrosideⅡin
cerebral ischemic injury were (1) ischemia 1.5h with 10mg/kg,
1.5h with 20mg/kg and 1.5h with 10mg/kg body weight according to
the expressions of MDA, NO and H2O2 in serum respectively, (2)
ischemia 1.5h with 10mg/kg, 1.5h with 20mg/kg and 1.5h with
20mg/kg body weight according to the expressions of MDA, NO and
H2O2 in brain tissue respectively.
Conclusion On the basis of the principle of the minimization of
medication dose and maximization of therapeutic time window, the
optimized composition of the therapeutic dose and time window in
cerebral ischemic injury was injecting picroside
Ⅱintraperitoneally with
10-20mg/kg body weight at ischemia 1.5h.
Keywords: picroside
Ⅱ, cerebral ischemia,
therapeutic dose, time window, MDA, NO, H2O2,
rats
|
|
|
|